ALAntoine-Guy Lopez

Antoine-Guy Lopez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antoine-Guy Lopez has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biochemical diagnosis of pheochromocytoma and paraganglioma: analytical challenges and perspectives for optimization

    by François Fraissinet, Théophile Charpentier, Hélène Girot, Valéry Brunel, Gaétan Prévost, Antoine-Guy Lopez


  • Rοle de la paracrinie dans la physiοpathοlοgie des hyperaldοsterοnismes primaires

    by Antoine-Guy Lopez

    Introduction : L’hyperaldostéronisme primaire (HAP) est une cause fréquente d’hypertension artérielle secondaire. Les mécanismes impliqués dans la physiopathologie des adénomes producteurs d’aldostérone (APA) restent partiellement élucidés. La présence d’une innervation à substance P (SP) et de récepteurs NK1 dans la zone glomérulée de la surrénale normale suggère un contrôle neurogène des cellules productrices d’aldostérone. L’objectif de ce travail est de déterminer la présence de fibres à SP et du récepteur NK1 dans une série d’APA et d’évaluer le rôle de ce neuropeptide dans la régulation de la sécrétion minéralocorticoïde.Matériels et Méthodes : Nous avons analysé 56 tissus d'APA à l'aide de techniques moléculaires, immunohistochimiques et fonctionnelles afin de caractériser l'expression de la SP et du récepteur NK1, et d'évaluer leur impact sur la sécrétion d'aldostérone.Résultats : Des fibres nerveuses SP-positives ont été détectées dans 90 % des tissus examinés, à la périphérie et au sein des adénomes, qui expriment également fortement le récepteur NK1. La comparaison des distributions du NK1R et de CYP11B2 en immunohistochimie a révélé que les deux protéines étaient localisées dans les mêmes régions dans 33 des 56 cas analysés. L’effet de la SP sur la production d'aldostérone a été observé dans 6 des 10 cultures d'APA, avec une réponse dose-dépendante dans un cas. L’aprépitant, un antagoniste du récepteur NK1R, a inhibé la sécrétion d'aldostérone induite par la SP dans 3 des 4 APA étudiés. Par ailleurs, nos résultats montrent que la sécrétion d'aldostérone par les tissus d'APA perifusés présente une pulsatilité spontanée, indépendante de toute stimulation externe. Après administration de SP, les profils de pulsatilité de la sécrétion d'aldostérone ont été modifiés dans 5 explants d'APA perifusés, avec une augmentation significative de l'aire sous la courbe, reflétant une augmentation globale de la sécrétion d'aldostérone.Conclusion : Ces résultats indiquent que le système SP-ergique et le récepteur NK1 pourraient contribuer à la physiopathologie des APAs et constituer une cible thérapeutique prometteuse pour le traitement pharmacologique de l'HAP.

  • Open Access

    Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone‐Producing Adenomas

    by Antoine‐Guy Lopez, Céline Duparc, Sylvie Renouf, Margot D’aGostino, Kelly De Sousa, Laurence Amar, Guillaume Defortescu, Gilles Manceau, Jean‐Christophe Sabourin, Fabio Luiz Fernandes‐Rosa, et al.

    Background: Aldosterone‐producing adenoma (APA) is a major cause of primary aldosteronism, the most frequent form of secondary hypertension. Although somatic mutations in ion channels within APA have been shown to activate Ca 2+ signaling and drive aldosterone production, the pathophysiology of primary aldosteronism remains partially understood. SP (Substance P), encoded by the TAC1 gene, is a neuropeptide of the tachykinin family, known for its role in stimulating aldosterone production through activation of the neurokinin 1 receptor (NK1R) in the human adrenal cortex. The aim of our work was to investigate the presence of SP nerve fibers and the NK1R in a large series of APA to assess the potential role of tachykinins in the pathophysiology of primary aldosteronism. Methods: Using molecular, immunohistochemical, and functional techniques, 56 APA tissues were analyzed to assess the expression of SP and NK1R and their impact on aldosterone secretion. Results: SP‐positive nerve fibers were detected in 90% of the APA tissues, localized both within and around the adenomas, which also showed strong NK1R expression. Functional studies revealed that SP stimulated aldosterone secretion in 6 of 10 APA cultures. The NK1R antagonist aprepitant inhibited SP‐induced aldosterone secretion in 3 of the 4 SP‐responsive APA cultures on which the antagonist was tested. Additionally, in perifused APA explants, SP influenced aldosterone pulsatility, resulting in enhanced mineralocorticoid secretion. Conclusions: These findings suggest that the SP‐NK1R signaling pathway may contribute to APA pathophysiology and represent a novel potential target for the pharmacological treatment of PA in a subset of patients.


  • Open Access

    Regulation of Aldosterone Secretion by Substance P and the NK1 Receptor in Aldosterone-Producing Adenomas

    by Antoine-Guy Lopez, Céline Duparc, Sylvie Renouf, Margot D’AGostino, Kelly De Sousa, Laurence Amar, Guillaume Defortescu, Gilles Manceau, Jean-Christophe Sabourin, Fabio Luiz Fernandes-Rosa, et al.

    Aldosterone-producing adenoma (APA) is a major cause of primary aldosteronism (PA), the most frequent form of secondary hypertension. Although somatic mutations in ion channels within APA have been shown to activate Ca 2+ signaling and drive aldosterone production, the pathophysiology of PA remains partially understood. Substance P (SP), encoded by the TAC1 gene, is a neuropeptide of the tachykinin family, known for its role in stimulating aldosterone production through activation of the neurokinin 1 receptor (NK1R) in the human adrenal cortex. The aim of our work was to investigate the presence of SP nerve fibers and the NK1 receptor in a large series of APA to assess the potential role of this neuropeptide in the pathophysiology of PA. We analyzed 56 APA tissues using molecular, immunohistochemical, and functional techniques to assess the expression of SP and NK1R and examine the action of SP on aldosterone secretion. SP-positive nerve fibers were detected in 90% of the APA tissues, appearing localized both within and around the adenomas, which also showed strong NK1R expression. Functional studies revealed that SP stimulated aldosterone secretion in 6 of 10 APA cultures. The NK1R antagonist aprepitant inhibited SP-induced aldosterone secretion in 3 of the 4 SP-responsive APA cultures on which the antagonist was tested. Additionally, in perifused APA explants, SP influenced aldosterone pulsatility, resulting in enhanced mineralocorticoid secretion. These findings suggest that the SP-NK1R signaling pathway may contribute to APA pathophysiology and represent a novel potential target for the pharmacological treatment of PA in a subset of patients.

  • Chapter 14: Post surgical follow-up of primary hyperparathyroidism

    by Sara Barraud, Antoine Guy Lopez, Emmanuelle Sokol, Fabrice Menegaux, Claire Briet


  • Young Athlete With Hypertension and Hypokalemia

    by Antoine-Guy Lopez, Dominique Guerrot

    We describe a 17-year-old woman diagnosed with severe hypertension during routine follow-up after the prescription of a combined oral contraceptive pill. Initially, due to her age, the estradiol-containing contraception, and high-level sport practice, physicians suspected drug-induced hypertension. Blood tests showed hypokalemia, and further investigations revealed pseudoaldosteronism. After the exclusion of toxic causes, Liddle syndrome was suspected and confirmed by genetic testing. Optimal therapeutic management was limited by anti-doping rules. This case report emphasizes the need for an early and systematic workup for causes of secondary hypertension in young patients and underlines diagnostic and therapeutic challenges in the management of hypertension in athletes.


  • Expression of LHCGR in Pheochromocytomas Unveils an Endocrine Mechanism Connecting Pregnancy and Epinephrine Overproduction

    by Antoine-Guy Lopez, Céline Duparc, Sylvie Renouf, Elise Machevin, Vincent Le Guillou, Jean-Christophe Sabourin, Guillaume Defortescu, Alexandre Buffet, Anne-Paule Gimenez-Roqueplo, Christophe Dubessy, et al.

    Background: The mechanisms by which pregnancy may unmask pheochromocytomas and paragangliomas are not totally understood. We hypothesized that gestational hormones may participate in the pathophysiology of catecholamine excess during pregnancy. We report a case of silent pheochromocytoma revealed in a pregnant woman by life-threatening adrenergic myocarditis. Methods: In vitro studies were conducted to investigate the effect of estradiol and the pregnancy hormone hCG (human chorionic gonadotropin) on epinephrine secretion by cultured cells derived from the patient’s tumor. Expression of LHCG (luteinizing hormone/chorionic gonadotropin) receptor was searched for in the patient’s tumor, and a series of 12 additional pheochromocytomas by real-time reverse transcription polymerase chain reaction and immunohistochemistry. LHCGR expression was also analyzed in silico in the pheochromocytomas and paragangliomas cohorts of the Cortico et Médullosurrénale: les Tumeurs Endocrines and The Cancer Genome Atlas databases. Results: hCG stimulated epinephrine secretion by cultured cells derived from the patient’s pheochromocytoma. The patient’s tumor expressed the LHCG receptor, which was colocalized with catecholamine-producing enzymes. A similar expression pattern of the LHCG receptor was also observed in 5 out of our series of pheochromocytomas. Moreover, in silico studies revealed that pheochromocytomas and paragangliomas display the highest expression levels of LHCG receptor mRNA among the 32 solid tumor types of The Cancer Genome Atlas cohort. Conclusions: Pregnancy may thus favor surges in plasma catecholamine and hypertensive crises through hCG-induced stimulation of epinephrine production by pheochromocytomas.


  • Hypertension With Negative Metaiodobenzylguanidine Scintigraphy

    by Antoine-Guy Lopez, Anna F. Dominiczak, Rhian Touyz, Markus Schlaich, Jean-Baptiste de Freminville, Laurence Amar


  • Open Access

    Protein kinase A drives paracrine crisis and WNT4-dependent testis tumor in Carney complex

    by Cyril Djari, Isabelle Sahut-Barnola, Amandine Septier, Ingrid Plotton, Nathanaëlle Montanier, Damien Dufour, Adrien Levasseur, James Wilmouth, Jean-Christophe Pointud, Fabio R. Faucz, et al.

    Large-cell calcifying Sertoli cell tumors (LCCSCTs) are among the most frequent lesions occurring in male Carney complex (CNC) patients. Although they constitute a key diagnostic criterion for this rare multiple neoplasia syndrome resulting from inactivating mutations of the tumor suppressor PRKAR1A, leading to unrepressed PKA activity, LCCSCT pathogenesis and origin remain elusive. Mouse models targeting Prkar1a inactivation in all somatic populations or separately in each cell type were generated to decipher the molecular and paracrine networks involved in the induction of CNC testis lesions. We demonstrate that the Prkar1a mutation was required in both stromal and Sertoli cells for the occurrence of LCCSCTs. Integrative analyses comparing transcriptomic, immunohistological data and phenotype of mutant mouse combinations led to the understanding of human LCCSCT pathogenesis and demonstrated PKA-induced paracrine molecular circuits in which the aberrant WNT4 signal production is a limiting step in shaping intratubular lesions and tumor expansion both in a mouse model and in human CNC testes.


  • La substance P et son récepteur dans les adénomes de Conn

    by A.G. Lopez, C. Duparc, S. Renouf, K. De Sousa, F. Fernandes-Rosa, S. Boulkroun, L. Amar, M.C. Zennaro, E. Louiset, H. Lefebvre